Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis.
In: Baylor University Medical Center Proceedings, Jg. 37 (2024-05-01), Heft 3, S. 389-393
Online
academicJournal
Zugriff:
A specific cause of superior vena cava (SVC) syndrome, SVC thrombosis, is a rare but known complication in cancer patients. Early identification and management of SVC thrombosis in lung cancer patients may lead to improved patient outcomes and a reduction in healthcare costs. We studied the racial and socioeconomic differences, length of stay, total hospital charges, and all-cause mortality outcomes in patients with lung cancer with and without SVC thrombosis using data from the National Inpatient Sample. Statistical analysis was performed on STATA. A total of 480,750 patients were hospitalized for lung cancer; 720 (0.15%) of these patients had SVC thrombosis. The lung cancer with SVC thrombosis cohort had a statistically higher proportion of Black patients. Patients with lung cancer presenting with SVC thrombosis had an increased hospital length of stay (10 vs 6 days, P < 0.001) and cost ($117,320 vs $80,806, P < 0.005) compared to those without SVC thrombosis. All-cause mortality in patients with lung cancer was 7.7% and the presence of SVC thrombosis significantly increased the odds of inpatient mortality (18.0%). Nonwhite races were associated with higher odds of mortality in lung cancer admissions. Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted. [ABSTRACT FROM AUTHOR]
Copyright of Baylor University Medical Center Proceedings is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis.
|
---|---|
Autor/in / Beteiligte Person: | Vakil, Jay ; Turk, Ekrem ; Cuartas-Mesa, Maria Cristina ; Deenadayalan, Vaishali ; Batra, Kunnal |
Link: | |
Zeitschrift: | Baylor University Medical Center Proceedings, Jg. 37 (2024-05-01), Heft 3, S. 389-393 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 0899-8280 (print) |
DOI: | 10.1080/08998280.2024.2317698 |
Sonstiges: |
|